Audioptics Medical Inc.

5 records totalling $569,943.00 CAD, from official Government of Canada open data.

Embed this chart

By department

National Research Council Canada $569,943 5 records

Records

Audioptics Medical Inc. $463,442.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2020-2021
Canada

Audioptics Medical is developing a novel diagnostic imaging system capable of seeing through the intact eardrum to visualize the middle ear to improve diagnostic precision in otolaryngology.

Audioptics Medical Inc. $46,483.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2019-2020
Canada

Audioptics is working towards the commercialization of a microscope that can see through the eardrum for diagnosing conductive hearing loss and planning ear surgeries. The project involves the de...

Audioptics Medical Inc. $28,852.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

Audioptics Medical Inc. $20,328.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
FY 2020-2021
Canada

The funding provided from the IAP program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

Audioptics Medical Inc. $10,838.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.